Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Oct 19, 2020
Date Accepted: Dec 10, 2020
Date Submitted to PubMed: Dec 14, 2020
Wearables in a Pandemic: What Are They Good For?
ABSTRACT
Recently, companies including Apple, Fitbit, and Garmin released new wearable blood oxygenation (SpO2) measurement technologies. While the release of these technologies has great potential for generating health-related information, it is important to acknowledge repercussions of consumer-targeted biometric monitoring technologies (consumer BioMeTs) that in practice are often used for medical decision-making. BioMeTs span both general wellness products and medical devices, and consumer BioMeTs intended for general wellness are not required to undergo a standardized and transparent evaluation process to ensure their quality and accuracy. A combination of the product functionality, marketing, and the circumstances of the global pandemic have inevitably led to the use of consumer BioMeTs that report health-related measurements to drive medical decision-making. We urge consumer BioMeT manufacturers to go beyond the bare minimum requirements described in FDA guidance when releasing information on wellness devices, and we also explore new methods and incentive systems that may result in a clearer public understanding of consumer BioMeT performance and intended use.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.